Laser Acupuncture for Otitis Media With Effusion in Children
The Effectiveness of Laser Acupuncture in the Management of Otitis Media With Effusion in Children
1 other identifier
interventional
32
1 country
1
Brief Summary
The goal of this clinical trial is to learn if laser acupuncture (LA) can improve middle ear function and reduce the recurrence of Otitis Media with Effusion (OME) in children. The main questions it aims to answer are: Does LA, when combined with standard treatment (decongestants), improve middle ear function as measured by tympanometry immediately after the 2-week intervention? Does LA, when combined with standard treatment, reduce the recurrence rate of OME as monitored over a 1-month period after the intervention? What is the safety profile of LA in this population, as measured by the incidence of adverse events? Researchers will compare active LA to sham LA (a placebo procedure with an inactive device) to determine if LA leads to meaningful improvements in children with OME. Participants will: Complete an initial assessment using tympanometry to confirm the diagnosis. Receive four sessions of either active LA or sham LA over a 2-week period. Complete a final assessment using tympanometry after the final session. Participate in a 1-month follow-up period with weekly monitoring for recurrence.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 17, 2025
CompletedFirst Posted
Study publicly available on registry
November 21, 2025
CompletedStudy Start
First participant enrolled
December 29, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
February 5, 2026
February 1, 2026
5 months
November 17, 2025
February 3, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Tympanogram Results
Improvement in middle ear function will be assessed using tympanometry. The outcome is measured as the proportion of participants whose tympanogram curve change from Type B (indicating effusion) to Type A (normal).
Baseline and immediately after the final (4th) therapy session at 2 weeks.
Secondary Outcomes (3)
Recurrence Rate of OME
From the end of the intervention over a 1-month follow-up period.
Time to First Recurrence
From the end of the intervention over a 1-month follow-up period.
Incidence of Adverse Events
At the end of each of the four acupuncture therapy sessions.
Study Arms (2)
Intervention Group
EXPERIMENTALActive laser acupuncture and standard decongestants.
Control Group
SHAM COMPARATORSham laser acupuncture and standard decongestants.
Interventions
Sham Laser Acupuncture involves placing the applicator of an inactive laser device onto the same acupoints (SI19, TE17, TE5, and LI4) for the same duration as the active group. The device is turned on, but the start button is not pressed, so no laser energy is emitted. All procedures, including aseptic preparation, timing, and handling of the device, are performed identically to the intervention group to maintain blinding. Participants will wear ear covers and the device's LCD panel will be covered. Participants continue their routine decongestant therapy.
Laser Acupuncture is performed for 40 seconds per point at acupoints SI19, TE17, TE5, and LI4 using a low-level laser device (785 nm, 50 mW, delivering an energy density of 12.73 J/cm²). The device is activated to emit laser energy. Standard aseptic procedures are followed. The laser applicator is held perpendicular to the skin without pressure. Participants continue their routine decongestant therapy.
Eligibility Criteria
You may qualify if:
- Children aged 2-10 years, both male and female.
- Diagnosed with OME with a Type B tympanogram curve, either unilateral or bilateral.
- No acute ear infection within the last 2 weeks.
- Willingness to participate in the study until completion and signed informed consent from a parent or legal guardian.
You may not qualify if:
- History of tympanic membrane perforation or previous ear surgery.
- Presence of severe OME complications, such as permanent hearing loss, tympanosclerosis, or cholesteatoma.
- Underwent laser acupuncture therapy for OME within the last three months.
- History of unstable systemic disease or other medical conditions that could interfere with the study, such as a history of uncontrolled seizures or epilepsy, a current high fever \>38°C, or malignancy/cancer in the ENT system.
- Presence of a mental disorder, inability to communicate well, or being uncooperative.
- Presence of wounds or skin lesions at the intended acupuncture point irradiation sites.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universitas Indonesia
Jakarta Pusat, DKI Jakarta, 10430, Indonesia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
KPEK FKUI-RSCM
The Health Research Ethics Commitee - Faculty of Medicine Universitas Indonesia and Dr. Cipto Mangunkusumo National Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Blinding will be applied to participants and outcome assessors. Group allocation will not be disclosed to them to minimize assessment bias.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 17, 2025
First Posted
November 21, 2025
Study Start
December 29, 2025
Primary Completion (Estimated)
May 31, 2026
Study Completion (Estimated)
June 30, 2026
Last Updated
February 5, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share